Biogen Prevails In Fed. Circ. MS Drug Dispute With Forward
The Federal Circuit on Wednesday backed Biogen MA in a dispute with Forward Pharma AS over which company was the first to invent a multiple sclerosis treatment, a decision that frees...To view the full article, register now.
Already a subscriber? Click here to view full article